Intelligent packaging can cut cost of trials; Stora Enso

By Nick Taylor

- Last updated on GMT

Related tags: Pharmacology

Using intelligent compliance packaging in clinical trials can result in “huge cost savings” and this will ensure demand even during a period of cost-cutting, according to a sales manager at Stora Enso.

Sari Hakili, sales manager, pharmaceutical solutions at Stora Enso Carton Board, explained that the cost of non-compliance makes intelligent packaging economically viable.

Intelligent packaging can reduce the workload on nurses and automate some processes, including data entry, leading to cost-savings, according to Hakli. Furthermore, as with all electronics, the cost will come down as the packaging is produced in larger volumes.

Hakli added that the packaging can be customised. These modifications can remind patients they have forgotten to take a tablet or alert them if they take their midday medication in the evening.

Related news

Related products

show more

Shifting the Biomanufacturing Paradigm

Shifting the Biomanufacturing Paradigm

BioContinuum™ Platform - MilliporeSigma | 01-Jul-2020 | Technical / White Paper

Adoption of next generation processing and technologies can enable improvements in productivity by streamlining workflows, reducing the manufacturing plant...

Bio4C™ ProcessPad Software Datasheet

Bio4C™ ProcessPad Software Datasheet

BioContinuum™ Platform - MilliporeSigma | 01-Jul-2020 | Data Sheet

Biopharmaceutical processes are complex and highly variable in nature. This can result in inconsistent and sometimes unpredictable process outcomes. To...

Related suppliers

Follow us

Products

View more

Webinars